We are live on ! Find out more
TYCC

Texas Yale Capital Corp Portfolio holdings

AUM $3.52B
1-Year Est. Return 52.63%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+52.63%
3 Year Est. Return
+137.29%
5 Year Est. Return
+205.78%
10 Year Est. Return
+676.18%
AUM
$1.56B
AUM Growth
+$13.7M
Cap. Flow
+$14.7M
Cap. Flow %
0.94%
Top 10 Hldgs %
46.18%
Holding
478
New
24
Increased
115
Reduced
91
Closed
22

Top Buys

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$1.98M
2
MRVL icon
Marvell Technology
MRVL
+$1.78M
3
QCOM icon
Qualcomm
QCOM
+$1.74M
4
CSCO icon
Cisco
CSCO
+$1.67M
5
CDNS icon
Cadence Design Systems
CDNS
+$1.66M

Sector Composition

Rank Sector Weight
1 Technology 37.63%
2 Financials 9.68%
3 Energy 8.66%
4 Industrials 6.23%
5 Consumer Discretionary 5.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
251
Emerson Electric
EMR
$88.7B
$843K 0.05%
11,512
IWF icon
252
iShares Russell 1000 Growth ETF
IWF
$128B
$830K 0.05%
15,788
TXRH icon
253
Texas Roadhouse
TXRH
$13.9B
$824K 0.05%
+9,448
New +$824K
NOW icon
254
ServiceNow
NOW
$130B
$819K 0.05%
10,850
IHE icon
255
iShares US Pharmaceuticals ETF
IHE
$1.65B
$815K 0.05%
14,430
KMB icon
256
Kimberly-Clark
KMB
$36.1B
$806K 0.05%
7,158
-875
-11% -$114K
ETRN
257
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$804K 0.05%
107,484
MTX icon
258
Minerals Technologies
MTX
$2.32B
$791K 0.05%
16,000
-124
-0.8% -$7.54K
DOC
259
DELISTED
PHYSICIANS REALTY TRUST
DOC
$787K 0.05%
52,300
XBI icon
260
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$786K 0.05%
9,905
DVY icon
261
iShares Select Dividend ETF
DVY
$23.6B
$782K 0.05%
7,295
AZN icon
262
AstraZeneca
AZN
$251B
$775K 0.05%
7,063
+505
+8% +$64.1K
LMT icon
263
Lockheed Martin
LMT
$139B
$762K 0.05%
1,973
+230
+13% +$96K
TFC icon
264
Truist Financial
TFC
$63.7B
$762K 0.05%
17,511
+36
+0.2% +$1.73K
COMB icon
265
GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF
COMB
$150M
$747K 0.05%
25,850
RHP icon
266
Ryman Hospitality Properties
RHP
$7.4B
$740K 0.05%
10,049
AVB icon
267
AvalonBay Communities
AVB
$26.3B
$732K 0.05%
3,975
+187
+5% +$37.7K
NOC icon
268
Northrop Grumman
NOC
$82.3B
$729K 0.05%
1,550
CRSP icon
269
CRISPR Therapeutics
CRSP
$5.25B
$712K 0.05%
10,900
+900
+9% +$65.2K
SPYD icon
270
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.66B
$712K 0.05%
+20,075
New +$808K
VRIG icon
271
Invesco Variable Rate Investment Grade ETF
VRIG
$1.85B
$705K 0.05%
28,636
-10,659
-27% -$264K
BNS icon
272
Scotiabank
BNS
$109B
$704K 0.05%
14,800
-1,550
-9% -$88.6K
TPVG icon
273
TriplePoint Venture Growth BDC
TPVG
$211M
$704K 0.05%
64,800
KHC icon
274
Kraft Heinz
KHC
$29.4B
$688K 0.04%
20,639
+300
+1% +$11.1K
DFUS
275
Dimensional US Equity ETF
DFUS
$21.7B
$683K 0.04%
17,599

Similar funds

Texas Yale Capital Corp's Q3 2022 Portfolio in Review

As of Q3 2022, Texas Yale Capital Corp held 478 positions worth $1.56B, up 0.89% from $1.55B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Texas Yale Capital Corp's Q3 2022 filing shows 24 new, 115 increased, 91 reduced and 22 closed positions. Its largest new stake was DraftKings: 124,673 shares worth $1.89M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $2.73M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Financials and Energy.

  • Texas Yale Capital Corp's largest Q3 2022 buy was DraftKings: 124,673 shares worth $1.89M.
  • Texas Yale Capital Corp added most to Qualcomm in Q3 2022, an estimated $1.74M increase.
  • Texas Yale Capital Corp's biggest Q3 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $2.73M.
  • Texas Yale Capital Corp fully exited PENN Entertainment in Q3 2022, selling an estimated $1.08M.
  • Texas Yale Capital Corp's ten largest holdings make up 46% of its $1.56B portfolio in Q3 2022.
  • Texas Yale Capital Corp opened 24 new positions and closed 22 in Q3 2022.
  • Texas Yale Capital Corp's portfolio value rose 0.89% quarter-over-quarter to $1.56B.

Based on Texas Yale Capital Corp's 13F filing for Q3 2022, filed 8 Nov 2022.